Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 153.00M | $ 166.00M | $ 166.50M | $ 101.40M | $ 115.10M |
Total Assets | $ 1.83B | $ 1.77B | $ 1.78B | $ 1.72B | $ 1.82B |
Total Debt | $ 520.20M | $ 479.90M | $ 497.10M | $ 508.40M | $ 620.10M |
Net Debt | $ 367.20M | $ 313.90M | $ 330.60M | $ 407.00M | $ 505.00M |
Total Liabilities | $ 808.50M | $ 717.90M | $ 768.10M | $ 730.30M | $ 878.00M |
Stockholders Equity | $ 1.02B | $ 1.05B | $ 1.01B | $ 993.70M | $ 940.30M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |